Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 156

    1.

    Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.

    Lundby Christensen L, Almdal T, Boesgaard T, Breum L, Dunn E, Gade-Rasmussen B, Gluud C, Hedetoft C, Jarloev A, Jensen T, Krarup T, Johansen LB, Lund SS, Madsbad S, Mathiesen E, Moelvig J, Nielsen F, Perrild H, Pedersen O, Roeder M, Sneppen SB, Snorgaard O, Tarnow L, Thorsteinsson B, Vaag A, Vestergaard H, Wetterslev J, Wiinberg N; CIMT Trial Group.

    Diabetes Obes Metab. 2009 Apr;11(4):315-22.PMID: 19267709 [PubMed - in process]Related articles

    2.

    Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes.

    Courrèges JP, Vilsbøll T, Zdravkovic M, Le-Thi T, Krarup T, Schmitz O, Verhoeven R, Bugáñová I, Madsbad S.

    Diabet Med. 2008 Sep;25(9):1129-31. No abstract available. PMID: 19183322 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

    Aaboe K, Knop FK, Vilsboll T, Vølund A, Simonsen U, Deacon CF, Madsbad S, Holst JJ, Krarup T.

    J Clin Endocrinol Metab. 2009 Feb;94(2):603-8. Epub 2008 Dec 2.PMID: 19050053 [PubMed - indexed for MEDLINE]Related articles

    4.

    Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.

    Højberg PV, Vilsbøll T, Zander M, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S.

    Diabet Med. 2008 Nov;25(11):1268-75.PMID: 19046215 [PubMed - indexed for MEDLINE]Related articles

    5.

    Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

    Højberg PV, Vilsbøll T, Rabøl R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S.

    Diabetologia. 2009 Feb;52(2):199-207. Epub 2008 Nov 27.PMID: 19037628 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Cystectomy in Denmark 2001-2005]

    Krarup T.

    Ugeskr Laeger. 2008 Jun 16;170(25):2260; author reply 2261. Danish. No abstract available. PMID: 18581651 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials.

    Madsbad S, Krarup T, Deacon CF, Holst JJ.

    Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):491-9. Review.PMID: 18542012 [PubMed - indexed for MEDLINE]Related articles

    8.

    GLP-1: physiological effects and potential therapeutic applications.

    Aaboe K, Krarup T, Madsbad S, Holst JJ.

    Diabetes Obes Metab. 2008 Nov;10(11):994-1003. Epub 2008 Apr 22. Review.PMID: 18435775 [PubMed - indexed for MEDLINE]Related articles

    9.

    Glucagon-like peptide-1, glucose homeostasis and diabetes.

    Holst JJ, Deacon CF, Vilsbøll T, Krarup T, Madsbad S.

    Trends Mol Med. 2008 Apr;14(4):161-8. Epub 2008 Mar 18. Review.PMID: 18353723 [PubMed - indexed for MEDLINE]Related articles

    10.

    Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.

    Højberg PV, Zander M, Vilsbøll T, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S.

    Diabetologia. 2008 Apr;51(4):632-40. Epub 2008 Feb 22.PMID: 18292985 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Treatment of invasive bladder cancer]

    Walter S, Krarup T.

    Ugeskr Laeger. 2008 Jan 21;170(4):213. Danish. No abstract available. PMID: 18282448 [PubMed - indexed for MEDLINE]Related articles

    12.

    Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.

    Vilsbøll T, Brock B, Perrild H, Levin K, Lervang HH, Kølendorf K, Krarup T, Schmitz O, Zdravkovic M, Le-Thi T, Madsbad S.

    Diabet Med. 2008 Feb;25(2):152-6. Epub 2008 Jan 14.PMID: 18201212 [PubMed - indexed for MEDLINE]Related articles

    13.

    The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.

    Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Holst JJ, Krarup T.

    Regul Pept. 2007 Dec 4;144(1-3):123-30. Epub 2007 Jul 13.PMID: 17692937 [PubMed - indexed for MEDLINE]Related articles

    14.

    Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Vølund A, Holst JJ, Krarup T.

    Diabetes. 2007 Aug;56(8):1951-9. Epub 2007 May 18.PMID: 17513701 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.

    Vilsbøll T, Zdravkovic M, Le-Thi T, Krarup T, Schmitz O, Courrèges JP, Verhoeven R, Bugánová I, Madsbad S.

    Diabetes Care. 2007 Jun;30(6):1608-10. Epub 2007 Mar 19. No abstract available. PMID: 17372153 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

    Knop FK, Vilsbøll T, Madsbad S, Holst JJ, Krarup T.

    Diabetologia. 2007 Apr;50(4):797-805. Epub 2007 Jan 16.PMID: 17225124 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.

    Knop FK, Vilsbøll T, Larsen S, Højberg PV, Vølund A, Madsbad S, Holst JJ, Krarup T.

    Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E324-30. Epub 2006 Sep 5.PMID: 16954337 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.

    Vilsbøll T, Agersø H, Lauritsen T, Deacon CF, Aaboe K, Madsbad S, Krarup T, Holst JJ.

    Regul Pept. 2006 Dec 10;137(3):168-72. Epub 2006 Aug 28.PMID: 16934887 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

    Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J, Vilsbøll T.

    Eur J Endocrinol. 2006 Sep;155(3):485-93.PMID: 16914604 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Role of gastrointestinal hormones in postprandial reduction of bone resorption.

    Henriksen DB, Alexandersen P, Bjarnason NH, Vilsbøll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C.

    J Bone Miner Res. 2003 Dec;18(12):2180-9.PMID: 14672353 [PubMed - indexed for MEDLINE]Related articles

    21.

    The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903.PMID: 14557471 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.

    Knop FK, Vilsbøll T, Larsen S, Madsbad S, Holst JJ, Krarup T.

    Diabetes Care. 2003 Sep;26(9):2581-7.PMID: 12941722 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

    Regul Pept. 2003 Jul 15;114(2-3):115-21.PMID: 12832099 [PubMed - indexed for MEDLINE]Related articles

    24.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.

    Vilsbøll T, Agersø H, Krarup T, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jan;88(1):220-4.PMID: 12519856 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.

    Sengeløv L, von der Maase H, Lundbeck F, Barlebo H, Colstrup H, Engelholm SA, Krarup T, Madsen EL, Meyhoff HH, Mommsen S, Nielsen OS, Pedersen D, Steven K, Sørensen B.

    Acta Oncol. 2002;41(5):447-56.PMID: 12442921 [PubMed - indexed for MEDLINE]Related articles

    27.

    Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.

    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

    Diabetologia. 2002 Aug;45(8):1111-9. Epub 2002 Jul 4.PMID: 12189441 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Management of stomas]

    Krarup T.

    Ugeskr Laeger. 2002 Mar 11;164(11):1527. Danish. No abstract available. PMID: 11924487 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Adrenal insufficiency after unilateral adrenalectomy for primary hyperaldosteronism]

    Kønig KB, Krarup T, Lund JO.

    Ugeskr Laeger. 2002 Jan 14;164(3):340-2. Danish. PMID: 11816333 [PubMed - indexed for MEDLINE]Related articles

    30.

    Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease.

    Rask-Madsen C, Ihlemann N, Krarup T, Christiansen E, Kober L, Nervil Kistorp C, Torp-Pedersen C.

    Diabetes. 2001 Nov;50(11):2611-8.PMID: 11679442 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    [Evaluation of surgical interventions in Denmark]

    Utzon J, Olsen PS, Bay-Nielsen M, Andersen KB, Christensen B, Endahl LA, Krarup T, Lucht U, Ottesen BS, Schroeder TV, Kehlet H.

    Ugeskr Laeger. 2001 Oct 8;163(41):5662-4. Danish. No abstract available. PMID: 11665468 [PubMed - indexed for MEDLINE]Related articles

    32.

    Long-term remission of transitional cell carcinoma after Bacillus Calmette-Guerin instillation in the renal pelvis.

    Hvarness H, Krarup T, Eldrup J.

    J Urol. 2001 Nov;166(5):1829. No abstract available. PMID: 11586237 [PubMed - indexed for MEDLINE]Related articles

    33.

    New QC process validates new blood gas technology at each measurement.

    Krarup T.

    Clin Chim Acta. 2001 May;307(1-2):75-85.PMID: 11369340 [PubMed - indexed for MEDLINE]Related articles

    34.

    No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose.

    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

    Diabet Med. 2001 Feb;18(2):144-9.PMID: 11251679 [PubMed - indexed for MEDLINE]Related articles

    35.

    Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

    Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ.

    Diabetes. 2001 Mar;50(3):609-13.PMID: 11246881 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.

    Vilsbøll T, Toft-Nielsen MB, Krarup T, Madsbad S, Dinesen B, Holst JJ.

    Diabetes Care. 2000 Jun;23(6):807-12.PMID: 10841001 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    High frequency of sub-optimal semen quality in an unselected population of young men.

    Andersen AG, Jensen TK, Carlsen E, Jørgensen N, Andersson AM, Krarup T, Keiding N, Skakkebaek NE.

    Hum Reprod. 2000 Feb;15(2):366-72.PMID: 10655308 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    [Essential testodynia]

    Krarup T.

    Ugeskr Laeger. 1998 Dec 14;160(51):7444-6. Danish. PMID: 9889662 [PubMed - indexed for MEDLINE]Related articles

    39.

    [Evaluation of blood loss and absorption of irrigating fluid in transurethral resection of the prostate]

    Poulsen EU, Wedel P, Krarup T.

    Ugeskr Laeger. 1998 Jul 27;160(31):4528-30. Danish. PMID: 9700309 [PubMed - indexed for MEDLINE]Related articles

    40.

    Na+-K+-2Cl- cotransport in Ehrlich cells: regulation by protein phosphatases and kinases.

    Krarup T, Jakobsen LD, Jensen BS, Hoffmann EK.

    Am J Physiol. 1998 Jul;275(1 Pt 1):C239-50.PMID: 9688855 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. Finasteride PSA Study Group.

    Oesterling JE, Roy J, Agha A, Shown T, Krarup T, Johansen T, Lagerkvist M, Gormley G, Bach M, Waldstreicher J.

    Urology. 1998 Apr;51(4A Suppl):58-63.PMID: 9586598 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Pressure pneumothorax after intercostal blockade]

    Krarup T.

    Ugeskr Laeger. 1997 Sep 22;159(39):5811. Danish. No abstract available. PMID: 9340890 [PubMed - indexed for MEDLINE]Related articles

    43.

    Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. The Finasteride PSA Study Group.

    Oesterling JE, Roy J, Agha A, Shown T, Krarup T, Johansen T, Lagerkvist M, Gormley G, Bach M, Waldstreicher J.

    Urology. 1997 Jul;50(1):13-8.PMID: 9218012 [PubMed - indexed for MEDLINE]Related articles

    44.

    [On the response "The scientific basis for the assessment of medical technology"]

    Birgens H, Jacobsen IA, Krarup T, Madsen JR, Aldershvile J, Mandrup-Poulsen T.

    Ugeskr Laeger. 1996 Dec 30;159(1):64-7. Danish. No abstract available. PMID: 9012078 [PubMed - indexed for MEDLINE]Related articles

    45.

    Occlusion of K+ in the Na+/K+/2Cl- cotransporter of Ehrlich ascites tumor cells.

    Krarup T, Jensen BS, Hoffmann EK.

    Biochim Biophys Acta. 1996 Oct 2;1284(1):97-108.PMID: 8865820 [PubMed - indexed for MEDLINE]Related articles

    46.

    [Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus]

    Hilsted JC, Madsbad S, Rasmussen MH, Hvidberg A, Krarup T, Ipsen H, Hansen B, Pedersen M, Djurup R, Oxenbøll B.

    Ugeskr Laeger. 1996 Jun 10;158(24):3451-5. Danish. PMID: 8650814 [PubMed - indexed for MEDLINE]Related articles

    47.

    Reconstitution of calyculin-inhibited K-Cl cotransport in dog erythrocyte ghosts by exogenous PP-1.

    Krarup T, Dunham PB.

    Am J Physiol. 1996 Mar;270(3 Pt 1):C898-902.PMID: 8638672 [PubMed - indexed for MEDLINE]Related articles

    48.

    Intranasal insulin therapy: the clinical realities.

    Hilsted J, Madsbad S, Hvidberg A, Rasmussen MH, Krarup T, Ipsen H, Hansen B, Pedersen M, Djurup R, Oxenbøll B.

    Diabetologia. 1995 Jun;38(6):680-4.PMID: 7672489 [PubMed - indexed for MEDLINE]Related articles

    49.

    Carcinoma implant in the abdominal wall after transurethral resection of bladder tumors using suprapubic trocar. A report of 3 cases.

    Bartholin J, Krarup T, Walter S, Therkildsen MH.

    Scand J Urol Nephrol Suppl. 1995;172:43-4.PMID: 8578255 [PubMed - indexed for MEDLINE]Related articles

    50.

    Pelvic lymphadenectomy (staging) in patients with bladder cancer laparoscopic versus open approach.

    Poulsen J, Krarup T.

    Scand J Urol Nephrol Suppl. 1995;172:19-21.PMID: 8578250 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...